Aadi Bioscience (AADI)

Aadi Bioscience (AADI) Stock Price & Analysis


AADI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.80 - $18.47
Previous Close$6.85
Average Volume (3M)129.70K
Market Cap
Enterprise Value-$4.42M
Total Cash (Recent Filing)$183.01M
Total Debt (Recent Filing)$1.72M
Price to Earnings (P/E)-2.5
May 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.73
Shares Outstanding24,395,117
10 Day Avg. Volume157,468
30 Day Avg. Volume129,702
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)1.05
Price to Sales (P/S)16.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.40
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.07
Price Target Upside414.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aadi Bioscience’s price range in the past 12 months?
Aadi Bioscience lowest stock price was $6.80 and its highest was $18.47 in the past 12 months.
    What is Aadi Bioscience’s market cap?
    Currently, no data Available
    When is Aadi Bioscience’s upcoming earnings report date?
    Aadi Bioscience’s upcoming earnings report date is May 11, 2023 which is in 43 days.
      How were Aadi Bioscience’s earnings last quarter?
      Aadi Bioscience released its earnings results on Mar 28, 2023. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.668 by $0.148.
        Is Aadi Bioscience overvalued?
        According to Wall Street analysts Aadi Bioscience’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aadi Bioscience pay dividends?
          Aadi Bioscience does not currently pay dividends.
          What is Aadi Bioscience’s EPS estimate?
          Aadi Bioscience’s EPS estimate is -$0.57.
            How many shares outstanding does Aadi Bioscience have?
            Aadi Bioscience has 24,395,117 shares outstanding.
              What happened to Aadi Bioscience’s price movement after its last earnings report?
              Aadi Bioscience reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.668. Following the earnings report the stock price went down -5.517%.
                Which hedge fund is a major shareholder of Aadi Bioscience?
                Currently, no hedge funds are holding shares in AADI


                Aadi Bioscience Stock Smart Score

                The Aadi Bioscience stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Aadi Bioscience

                Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 17, 2011 and is headquartered in Cincinnati, OH.


                Top 5 ETFs holding AADI

                Market Value
                Smart Score
                Dimensional US Core Equity Market ETF
                Up to five ETFs with an Outperform Smart Score that hold AADI. The ETFs are listed according to market value of AADI within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Kinnate Biopharma
                PepGen Inc.
                Omega Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis